Clinical Trial

Results of the Use of Two Stentrievers Simultaneosly Compared With One as a Primary Treatment in Acute Ischemic Stroke

Study acronym: DIVERSO
Recruiting
View on ClinicalTrials.gov →
Summary
Several studies have demonstrated that simultaneous treatment with two stentrievers (STs) as rescue treatment is very effective, with high recanalization rates even in this group of patients where other revascularization techniques have failed. There has been no observed increase in hemorrhagic complications. Recently, a prospective study has been published where treatment with two ST has been shown to be effective and safe if used as a first-choice treatment (not as rescue) with a successful recanalization rate (eTICI 2c/3) after the first pass of 69%. These results have been reinforced after the publication of a randomized study that confirms, in vitro, the superiority of using two ST over one.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2023-07-03; most recent amendment 2025-07-24.
Status change: Not Yet Recruiting → Recruiting 2025-06-22
Trial Details
NCT Number NCT05930145
Lead Sponsor Fundación EPIC
Conditions Stroke, Thrombectomy, Arterial Occlusive Diseases
Enrollment 200 participants
Start Date 2025-03-14
Primary Completion 2026-09-01 (estimated)
Study Completion 2026-10-01 (estimated)
Updated on ClinicalTrials.gov 2025-07-28